Q13133 (NR1H3_HUMAN) Homo sapiens (Human)
Oxysterols receptor LXR-alpha UniProtKBInterProSTRINGInteractive Modelling
447 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3);
4 identical sequences: Homo sapiens: F1D8N1; Pan troglodytes: A0A6D2XX46, K7AUZ1; Pan paniscus: A0A2R9BV37
Available Structures
7 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure of LXRalpha in complex with tert-butyl benzoate analog, compound 32b |
Heteromer Q15788; | 100.0 | 2×4KQ; | |||
| Crystal structure of LXRalpha in complex with tert-butyl benzoate analog, compound 4 |
Heteromer Q15788; | 100.0 | 2×4KM; | |||
| Identification of LXRbeta selective agonists for the treatment of Alzheimer's Disease |
Heteromer Q15788; | 100.0 | 2×668; 2×SO4; | |||
| X-ray structure of benzisoxazole synthetic agonist bound to the LXR-alpha |
Heteromer Q15788; | 100.0 | 2×SO4; 2×O90; | |||
| X-ray structure of benzisoxazole urea synthetic agonist bound to the LXR-alpha |
Heteromer Q15788; | 100.0 | 2×O40; 2×SO4; | |||
| X-ray structure of GW3965 synthetic agonist bound to the LXR-alpha |
Heteromer Q15788; | 100.0 | 2×965; 2×SO4; | |||
| Crystal structure of the LXRalfa-RXRbeta LBD heterodimer |
Heteromer P28702; Q15596; | 100.0 | 1×MEI; 1×444; | |||
12 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 4nqa.1.B | monomer | 0.74 | 2×ZN; | 73.70 | ||
| 4nqa.2.B | monomer | 0.74 | 2×ZN; 1×965; | 73.70 | ||
| 5uan.1.B | monomer | 0.65 | 1×ZN; | 34.23 | ||
| 7wnh.4.A | monomer | 0.62 | 1×ZN; | 29.43 | ||
| 7wnh.2.A | monomer | 0.61 | 2×ZN; | 29.43 | ||
| 3dzy.1.B | monomer | 0.61 | 1×ZN; | 28.65 | ||
| 4iqr.2.B | monomer | 0.57 | 2×ZN; | 30.72 | ||
| 4iqr.2.A | monomer | 0.57 | 2×ZN; | 30.72 | ||
| 7prw.1.B | monomer | 0.57 | 2×ZN; | 24.25 | ||
| 3dzy.1.A | monomer | 0.52 | 2×ZN; | 31.09 | ||
| 5uan.1.A | monomer | 0.52 | 1×ZN; | 31.49 | ||
| 4nqa.2.A | monomer | 0.51 | 1×ZN; | 31.49 | ||
23 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 4nqa.1.B | monomer | 0.67 | 2×ZN; | 68.65 | ||
| Isoform 2 | 4nqa.2.B | monomer | 0.65 | 2×ZN; | 68.65 | ||
| Isoform 2 | 5uan.1.B | monomer | 0.63 | 1×ZN; | 30.82 | ||
| Isoform 2 | 7wnh.2.A | monomer | 0.58 | 2×ZN; | 27.68 | ||
| Isoform 2 | 4iqr.1.B | monomer | 0.58 | 2×ZN; | 28.87 | ||
| Isoform 2 | 4iqr.2.A | monomer | 0.57 | 2×ZN; | 28.87 | ||
| Isoform 2 | 3dzy.1.A | monomer | 0.57 | 2×ZN; | 26.96 | ||
| Isoform 2 | 3dzy.1.B | monomer | 0.56 | 1×ZN; | 28.37 | ||
| Isoform 2 | 7wnh.4.A | monomer | 0.56 | 1×ZN; | 27.68 | ||
| Isoform 2 | 7prv.1.B | monomer | 0.54 | 2×ZN; | 22.68 | ||
| Isoform 2 | 7prw.1.A | monomer | 0.54 | 2×ZN; | 22.68 | ||
| Isoform 3 | 4nqa.1.B | monomer | 0.75 | 2×ZN; | 73.70 | ||
| Isoform 3 | 4nqa.2.B | monomer | 0.74 | 2×ZN; 1×965; | 74.38 | ||
| Isoform 3 | 5uan.1.B | monomer | 0.66 | 1×ZN; | 34.23 | ||
| Isoform 3 | 7wnh.4.A | monomer | 0.62 | 1×ZN; | 29.04 | ||
| Isoform 3 | 7wnh.2.A | monomer | 0.62 | 2×ZN; | 29.04 | ||
| Isoform 3 | 3dzy.1.B | monomer | 0.61 | 1×ZN; | 28.94 | ||
| Isoform 3 | 4iqr.2.B | monomer | 0.59 | 2×ZN; | 31.03 | ||
| Isoform 3 | 4iqr.2.A | monomer | 0.58 | 2×ZN; | 31.03 | ||
| Isoform 3 | 7prv.1.B | monomer | 0.58 | 2×ZN; | 24.25 | ||
| Isoform 3 | 3dzy.1.A | monomer | 0.54 | 2×ZN; | 30.25 | ||
| Isoform 3 | 5uan.1.A | monomer | 0.53 | 1×ZN; | 31.49 | ||
| Isoform 3 | 4nqa.2.A | monomer | 0.51 | 1×ZN; | 31.49 | ||